FDA Inspection
AptaPharma Inc.AptaPharma Inc. – FDA Inspection, May 15, 2023
Record Details
This FDA Inspection record concerns AptaPharma Inc., with an inspection on May 15, 2023, issued by the New Jersey District Office.
- Company
- AptaPharma Inc.
- Inspection Date
- May 15, 2023
View Company Profile
ID · acbc1cae-f7f4-45ce-a9dd-baac18f57175
Inspection Facts
- Inspection number
- 1205203
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.122(e)Destruction of obsolete labeling
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AptaPharma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | VAI | New Jersey District Office | Drug Quality Assurance |
| October 24, 2024 | Not classified | New Jersey District Office | |
| September 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AptaPharma Inc.
- FDA Inspection 1331256 - 2026-08-14
- FDA Inspection 1231140 - 2024-10-24
- FDA Inspection 1102699 - 2019-09-25
- FDA Inspection 1045668 - 2018-03-16
- FDA Inspection 884304 - 2014-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.